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The TATA box binding protein (TBP) nucleates the
assembly of preinitiation complexes on genes transcribed
by all three eukaryotic RNA polymerases. TBP has been
known about for quite some time and is thought to have
a general role in directing the initiation of transcription.
The recent discovery of a Drosophila TBP homologue,
called TBP-related factor (TRF) [1], raises several
important questions about the roles alternative forms of
TBP may play in differential gene expression. The 
information available to date suggests that TRF may be
the founding member of a family of tissue-specific
general transcription factors.
TRF was initially discovered by a mutation that caused a
leg shaking (‘shaker’) phenotype in anesthetized
Drosophila [2]. The product of the affected gene, TRF,
was found to be highly homologous to TBP (Figure 1),
hence its name. In situ hybridization showed that TRF is
expressed in the central nervous system (CNS) and male
reproductive organs, while immunofluorescence of poly-
tene chromosomes narrowed TRF’s binding sites to a
subset of fly genes [1]. Biochemical analyses showed that
TRF can substitute for TBP in basal transcription of
TATA-dependent reporter genes in vitro and support acti-
vated transcription in vivo [1]. Collectively, the data point
to a role for TRF in CNS gene regulation [3]. We shall
discuss whether the differences between TRF and TBP
are sufficient to explain why a cell would require alterna-
tive forms of TBP and how these homologues would be
designed and function.
The high degree of sequence homology suggests that
TRF can fold into the same structure as TBP [4]. Based
on this premise, information obtained from structural and
Figure 1
Lalign comparison of three TBPs and TRF.
The residues comprising the carboxy-terminal
region of Drosophila TBP are shown in the
top line, with the divergent residues in human
TBP, yeast TBP and TRF indicated below
(divergent regions are highlighted in red). The
residues of TBP that form β strand 1, helix 1,
helix 2, β strand 1′, helix 1′, and helix 2′ are
denoted above the sequence. Residues
involved in binding the TATA box are bold,
and those involved in interacting with TFIIA
[23], TFIIB [8], TAFIIs [5,13] and Brf/B′′ [6]
are underlined with blue, purple, green and
yellow lines, respectively. The residue number
above the sequence denotes the position of
the Drosophila residues.
Drosophila	 PGIVPQLQNIVSTVNLCCKLDLKKIALHARNAEYNPKRFAAVIMRIREPR
Human	 S               G      T   R
Yeast	 S    T     A  T G R    TV                        K
TRF	 HE --R     A FSVN E    A NSRT  S  S    RG    MHS

Drosophila	 TTALIFSSGKMVCTGAKSEDDSRLAARKYARIIQKLGFPAKFLDFKIQNM
Human	                    EQ          VV
Yeast 	       A     V         K  S         I  A   T      I
TRF 	 C     RT  VI    RN IEADIGS  F   L      V  MEY L  I
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mutagenesis studies of TBP could, in principle, be applic-
able to TRF. We undertook such a comparison using, as
guides, mutagenesis results and the known structures of
TBP–TATA complexes with TFIIA and TFIIB [4–7]. We
deferred to structural information, where available, and
picked those mutagenesis studies where an attempt had
been made to correlate structure and function both in vitro
and in vivo. Figure 1 shows a ‘lalign’ comparison of TRF
with TBP from Drosophila, humans and yeast, and
Figure 2 shows a ribbon diagram of human TBP. The red
lettering in Figure 1, and the red ribbons in Figure 2, cor-
respond to regions of TBP and TRF that diverge by at
least five out of six residues. 
TBP contains a 180 amino-acid core domain comprising
two pseudo-symmetric structural halves. Together, the
halves fold into a 10-stranded, anti-parallel β sheet and four
α helices. The β sheet forms a concave undersurface,
which binds in the DNA minor groove, making extensive
contacts with the exposed groups of base pairs and the
phosphate backbone (Figure 2a). The helices are displayed
on the upper, solvent-exposed surface of the DNA-bound
protein. Phenylalanines within two symmetrically disposed
regions, called the stirrups, intercalate between the first
and last base pairs of the TATA box, bending the helix by
80° and unwinding the DNA by 105° [4].
TBP normally associates with polymerase-specific TBP-
associated factors (TAFs), some of which, like TBP, are
conserved from yeast to humans. The major complex of
RNA polymerase II TAFs (TAFIIs) and TBP is called
TFIID [8]. TFIID, in combination with the other general
factors (TFIIA, TFIIB, TFIIE, TFIIF and TFIIH),
assembles into a transcription complex at a core
polymerase II promoter. Several alternative forms of
TFIID have been identified bearing different subsets of
TAFs [9]. TBP also associates with polymerase I-specific
[10] or polymerase III-specific TAFs, such as Brf [7]. TBP
is also a component of a complex called SNAPc, which in
mammalian cells mediates U6 transcription by polymerase
III and U2 transcription by polymerase II. In the U6 case,
the TBP-containing SNAPc complex is recruited by the
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Figure 2
An attempt to relate the TBP–TRF sequence comparison to the known
structure of TBP. (a) A ribbon diagram of human TBP [24] bound to
DNA. The divergent regions between Drosophila TBP and TRF are
illustrated in red. (b) In this view of the divergent regions, the figure has
been rotated 90° relative to (a). (c) Using the same view as in (a), the
residues that interact with TFIIA, TFIIB, TAFIIs and Brf/B′′ are colored
blue, purple, green and yellow, respectively (the same color scheme as
in Figure 1). Residues involved in more than one function are
highlighted in black. (d) In this view of the binding sites, the figure has
been rotated exactly 90° relative to (c).
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non-conserved amino terminus of another TBP molecule
bound at a TATA box [11]. TBP thus plays many impor-
tant transcriptional roles in a cell. Does TRF play similar
roles, or is it designed to interact with different TAFs or
general factors?
Sequence comparisons showed that the DNA-binding
surfaces of TRF and Drosophila TBP are highly con-
served, explaining, at least in part, the ability of TRF to
bind a TATA box. As illustrated in Figure 2, the binding
sites for TFIIA (blue) and TFIIB (purple), located in part
on opposing stirrups of TBP, also show a high, albeit
imperfect, level of conservation. This again may help to
explain why TRF can substitute for TBP in basal
polymerase II transcription. In contrast, the proteins
exhibited six stretches of divergence located in three
symmetric regions: helices 1 and 1′, 2 and 2′, and strands
1 and 1′.
Although the role of the strands is unknown, the surface
helices of TBP are predicted to interact with TAFs. In
yeast and human TBP, for example, substitution of the
residue analogous to arginine 245 of Drosophila TBP in the
unconserved portion of helix 2 severely diminishes poly-
merase III and activated polymerase II transcription in
vivo [5,7,12]. Furthermore, the same position is part of the
TAFII250- and Brf-binding sites identified in vitro
[5,6,13]. The non-conserved region of helix 1 also contains
residues implicated in Brf binding [6,7]. The situation is
more complicated, however, as some residues implicated
in TAF binding are apparently conserved [5–7]. Surpris-
ingly little is known of the helix 1′ and 2′ function,
although 2′ has been predicted to interact with TAFs [12]
and TFIIF [14]. Furthermore, helices 1′ and 2′ are less
conserved than helices 1 and 2 in TRF and in TBPs from
different species. Lastly, one might predict from studies
in mammalian systems that, as TRF lacks an amino-termi-
nal region, it may not be recruited by the SNAPc complex
to U6-type promoters [11]. This recruitment step has not,
however, been formally characterized in Drosophila.
Taken together, the data suggest that a number of TAF
binding sites are not conserved in TRF. These include the
binding sites for the ubiquitous polymerase II TAFII250
and the polymerase III TAF Brf, and possibly even the
SNAPc interaction surface. Indeed, the divergence sug-
gests that TRF may be designed to interact with novel
TAFs that, given TRF’s conserved surfaces for interacting
with TFIIA and TFIIB and its ability to function in basal
transcription, may act in polymerase II gene regulation.
Indeed, there is immunoprecipitation evidence that TRF
binds novel TAFs ranging in size from 35–180 kDa [2].
What might be the function of these TAFs? Although
TAFs permit activated transcription in vitro, probably
through direct activator–TAF interactions, recent studies
have highlighted their role in core promoter recognition.
Genetic studies by Shen and Green [15] have identified
several TAF-responsive yeast genes, most notably genes
involved in controlling the cell cycle and growth. Inacti-
vation of TAFII145 leads to a G1/S cell-cycle block, and
is accompanied by a decrease in transcription of G1
cyclins and some type B cyclins. These results confirmed
previous studies in the hamster ts13 cell line, which con-
tains a mutation in TAFII250, the mammalian homo-
logue of yeast TAFII145 ([16] and references therein).
By analyzing the effects of TAFII145 on chimeric pro-
moters in yeast, the core promoter was shown to deter-
mine responsiveness to the TAF [15]. Analogous
promoter swap experiments with the cyclin A gene in
mammalian cells, however, suggest that TAFII250 influ-
ences both core promoter recognition and activated tran-
scription [16]. These studies confirmed numerous
biochemical experiments [17–21] suggesting that TAFs
recognize multiple downstream sequence elements
flanking the TATA box. On the basis of these results, we
speculate that the TAFs that associate with TRF may
recognize unique promoter elements of genes expressed
specifically in the CNS, CNS-specific transcriptional
activators or both.
Why would a cell employ a cell-specific TBP-homologue
like TRF to bind what may be cell-specific TAFs [22],
rather than, for example, simply designing the TAFs to
bind a unique surface on TBP? One possible explanation
is that different TAF-binding sites on TBP encompass
distinct portions of the surface (Figure 2c,d). Although the
polymerase II and polymerase III TAFs on TBP interact
with a few common residues, probably to ensure mutually
exclusive binding, mutagenesis data suggest they bind pri-
marily to different surfaces. Because TBP already inter-
acts with the general factors, components of the SNAPc
fraction and the polymerase I, II and III TAFs, there
simply may not be enough room to accommodate further,
cell-type-specific TAFs.
Tjian and colleagues [2] noted that other TBP homo-
logues are evident in mouse and human (but not yeast)
sequence databases. TRF may therefore be the founding
member of a family of TBP homologues, different
members of which interact with different subsets of
TAFs in a tissue-specific fashion. If the divergent sur-
faces of TRF are important for TAF interactions, then
two key predictions follow. First, that altered forms of
TRF with mutations that confer the ability to bind Brf
and TAFII250 in vitro will allow TRF to function nor-
mally in polymerase II and III transcription in vivo.
Second, that other TRF-family members will diverge on
the same critical surfaces as TRF and again interact with
tissue-specific TAFs, such as the B-cell-specific
TAFII105 [22]. It will be exciting to determine how this
seemingly novel form of regulation contributes to differ-
ential gene expression.
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